BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3539895)

  • 1. Biochemical studies on a factor isolated from Klebsiella K43-BTS1 that cross-reacts with cells from HLA-B27 positive patients with ankylosing spondylitis.
    Upfold LI; Sullivan JS; Geczy AF
    Hum Immunol; 1986 Nov; 17(3):224-38. PubMed ID: 3539895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical characterization of Klebsiella antigens which specifically modify an HLA-B27-associated cell-surface component.
    Sullivan J; Upfold L; Geczy AF; Bashir HV; Edmonds JP
    Hum Immunol; 1982 Dec; 5(4):295-307. PubMed ID: 6186656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a factor(s) present in Klebsiella culture filtrates that specifically modifies an HLA-B27-associated cell-surface component.
    Geczy AF; Alexander K; Bashir HV; Edmonds JP
    J Exp Med; 1980 Aug; 152(2 Pt 2):331s-340s. PubMed ID: 6157768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
    Georgopoulos K; Dick WC; Goodacre JA; Pain RH
    Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of anti-Klebsiella K43 antiserum and lymphocytes from HLA-B27-positive patients with ankylosing spondylitis.
    Struthers GR
    Lancet; 1985 Mar; 1(8431):764. PubMed ID: 2858037
    [No Abstract]   [Full Text] [Related]  

  • 6. Search for Klebsiella cell wall components cross-reactive with lymphocytes of B27+ AS+ individuals.
    Druery C; Bashir H; Geczy AF; Alexander K; Edmonds J
    Hum Immunol; 1980 Sep; 1(2):151-60. PubMed ID: 7021488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
    J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens as carrier molecules.
    van Rood JJ
    Hum Immunol; 1986 Nov; 17(3):246-9. PubMed ID: 3491813
    [No Abstract]   [Full Text] [Related]  

  • 9. Klebsiella 'modifying factor': binding studies with HLA-B27+ and B27- lymphocytes.
    Trapani JA; McKenzie IF
    Ann Rheum Dis; 1985 Mar; 44(3):169-75. PubMed ID: 2579614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population.
    Archer JR; Stubbs MM; Currey HL; Geczy AF
    Lancet; 1985 Feb; 1(8424):344-5. PubMed ID: 2857398
    [No Abstract]   [Full Text] [Related]  

  • 11. The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitis.
    Alexander K; Edwards C; Misko IS; Geczy AF; Bashir HV; Edmonds JP
    Clin Exp Immunol; 1981 Jul; 45(1):158-64. PubMed ID: 6171370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modification of HLA-B27-positive lymphocytes by the culture filtrate of Klebsiella K43 BTS 1 is a metabolically active process.
    Sullivan JS; Geczy AF
    Clin Exp Immunol; 1985 Dec; 62(3):672-7. PubMed ID: 3878756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS; Geczy AF
    Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a Klebsiella plasmid involved in the aetiology of Ankylosing Spondylitis in HLA-B27-positive individuals?
    Cameron FH; Russell PJ; Sullivan J; Geczy AF
    Mol Immunol; 1983 May; 20(5):563-6. PubMed ID: 6348514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera.
    Avakian H; Welsh J; Ebringer A; Entwistle CC
    Br J Exp Pathol; 1980 Feb; 61(1):92-6. PubMed ID: 6990955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivity of anti-Klebsiella K43 BTS 1 serum and lymphocytes of patients with ankylosing spondylitis: antipodean curiosity?
    Geczy AF; Prendergast JK; McGuigan LE; Upfold LI; Sullivan JS
    Lancet; 1985 May; 1(8438):1169. PubMed ID: 2860379
    [No Abstract]   [Full Text] [Related]  

  • 17. IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis and acute anterior uveitis.
    Sprenkels SH; Van Kregten E; Feltkamp TE
    Clin Rheumatol; 1996 Jan; 15 Suppl 1():48-51. PubMed ID: 8835503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A factor shed by lymphoblastoid cell lines of HLA-B27 positive patients with ankylosing spondylitis, specifically modifies the cells of HLA-B27 positive normal individuals.
    Orban P; Sullivan JS; Geczy AF; Upfold LI; Coulits N; Bashir HV
    Clin Exp Immunol; 1983 Jul; 53(1):10-6. PubMed ID: 6191893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls.
    Baines M; Ebringer A; Avakian H; Samuel D; James DC
    Scand J Rheumatol; 1990; 19(5):341-9. PubMed ID: 1699267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B27, Klebsiella, and ankylosing spondylitis.
    Geczy AF; Yap J
    Lancet; 1979 Mar; 1(8118):719-20. PubMed ID: 85952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.